Koyfin Home > Directory > Health Care > Amicus Therapeutics > EV / EBITDA (ltm)

Amicus Therapeutics EV / EBITDA (ltm) Chart (FOLD)

Amicus Therapeutics annual/quarterly EV / EBITDA (ltm) from 2019 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Amicus Therapeutics Market Cap for the quarter ending March 03, 2018 was $2,811m a 48.80% increase of 1,372m year over year
  • Amicus Therapeutics Price / Book for the quarter ending March 03, 2018 was 7.12 a 34.98% increase of 2.49 year over year
  • Amicus Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $2,617m a 49.70% increase of 1,301m year over year
View Chart On Koyfin